Home
The Company
Technology Development
Our Strategy
Medical Applications
Non Medical Applications
Contact

Breast Cancer

One in every eight women will develop breast cancer in their lifetime.

  • More than 200,000 women in the United States will be diagnosed with breast cancer this year, and approximately 40,000 will die from the disease.
  • Today, x-ray mammography and breast self-examination are the primary means of detection, with ultrasound and surgical biopsy used for advanced diagnosis.
  • More than 45 million mammograms were preformed in the U.S. alone in 2000.

While x-ray mammography is the current screening convention for breast examination, it has some significant limitations. The discomfort of breast compression is a user acceptance barrier, and imaging of dense breasts, very large breasts and very small breasts is next to impossible.

InnerVision is developing an ultra high resolution diagnostic technology that could enable practitioners to detect breast cancer well before the tumor is metastasising.

Flash Ultrasound™ vs X-ray Mammography

Promise of superior image resolution as compared to traditional x-ray mammography; which could result in:

  • Improved clinical diagnostics
  • Earlier detection which could mean earlier intervention
  • Fewer false positive results
  • Fewer false negative results

Safety:

  • No radiation exposure

It is envisioned that with Flash Ultrasound™ physicians would be able to better image/diagnose:

  • Dense breasts
  • Very large breasts
  • Very small breasts

Note: Flash Ultrasound™ is an Investigational Device. It is not currently available for sale. Confirmation of safety and effectiveness is yet to be determined.